Sun Pharma sells CNS divisions to Strides Arcolab

Mumbai;Sept 19: Sun Pharmaceutical Industries Ltd. on Saturday said the company has signed agreement with Strides Arcolab Ltd. to sell central nervous system (CNS) portfolio of erstwhile Ranbaxy Laboratories Ltd for Rs1,65 crore.

The agreement involves transfer of two marketing divisions 'Solus' and 'Solus Care', along with employees to Strides, statement from Sun Pharma said.

The transaction is subject to approval from the Competition Commission of India and other customary closing conditions.

"All other terms and conditions of the transaction are confidential," both the companies said in a joint filing with the stock exchanges.

Sanitary napkin exempted from GST

New Delhi : Delhi Deputy Chief Minister Manish Sisodia on Saturday said sanitary napkin has been exempted from the Goods and Services Tax (GST).Speaki...

IMG Group comes up with reality based web series "SURVIVORSS"

New Delhi : IMG Group, who has always recognized new and fresh talent and gifted the industry with amazing actors and models, is coming up with a new ...

Enerparc India commissions rooftop solar project for Bharat Fritz Werner

Bengaluru : Enerparc India, a subsidiary of global solar solution provider Enerparc AG is glad to announce the commissioning of 980 kWp solar project ...

Select CITYWALK adds Japanese luxury brand Onitsuka Tiger to its growing portfolio

New Delhi : Introducing the Japanese Luxury Footwear Brand, Onitsuka Tiger, Select CITYWALK, the most popular shopping Centre in Delhi NCR, becomes ga...